Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 4, 1998, Pages 526-534

  Humphries, Steve E ^a   Nicaud, Viviane ^b   Margalef, Joaquim ^c   Tiret, Laurence ^b   Talmud, Philippa J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b INSERM   (France)

^c UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Lipoprotein lipase HindIII polymorphism; Offspring; Ser447X

Indexed keywords

LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; EUROPE; FAMILY HISTORY; FEMALE; GENE FREQUENCY; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTRIGLYCERIDEMIA; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POSTPRANDIAL STATE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031955802     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.4.526     Document Type: Article

References (19)

1. The EARS group. The European Atherosclerosis Research Study (EARS): design and objectives. Int J Epidemiol. 1994;23:465-471.
2. The EARS group. The distribution of fasting plasma lipid concentrations in the offspring of men with premature coronary heart disease in Europe: the EARS Study. Int J Epidemiol. 1994;23:472-481.
3. Rosseneu M, Fruchart JC, Bard JM, Nicaud V, Vinaimont N, Cambien F, De Backer G. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects: the EARS Study: European Atherosclerosis Research Study. Circulation. 1994;89:1967-1973.
4. Taskinen MR, Kuusi T. Enzymes involved in triglyceride hydrolysis. Baillieres Clin Endocrinol Metab. 1987;1:639-666.
5. Auwerx J, Leroy P, Schoonjans K. Lipoprotein lipase: recent contributions from molecular biology. Crit Rev Clin Lab Sci. 1992;29:243-268.
6. Heizmann C, Kirchgessner T, Kwiterovich PO, Ladias JA, Derby C, Antonarakis SE, Lusis AJ. DNA polymorphism haplotypes of the human lipoprotein lipase gene: possible association with high density lipoprotein levels. Hum Genet. 1991;86:578-584.
7. Fisher KI, FitzGerald GA, Lawn RM. Two polymorphisms in the human lipoprotein lipase (LPL) gene. Nucleic Acids Res. 1987;15:7657.
8. Heinzmann C, Ladias J, Antonarakis S, Kirchgessner T, Schotz M, Lusis AJ. RFLP for the human lipoprotein lipase (LPL) gene: HindIII. Nucleic Acids Res. 1987;15:6763.
9. Hata A, Robertson M, Emi M, Lalouel J-M. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 1990;18:5407-5411.
10. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: associations in normal and hypertriglyceridaemic subjects. Atherosclerosis. 1989;79:85-91.
11. Ahn YI, Kamboh MI, Hamman RF, Cole SA, Ferrell RE. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J Lipid Res. 1993;34:421-428.
12. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis. 1992;97:171-185.
13. Thorn JA, Chamberlain JC, Alcolado JC, Oka K, Chan L, Stocks J, Galton DJ. Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis. 1990;85:55-60.
14. Mailly F, Tugrul Y, Reymer PWA, Bruin T, Seed M, Groenemeyer BF, Asplund-Carlson A, Vallance D, Winder AF, Miller GJ, Kastelein JJP, Hamsten A, Olivecrona G, Humphries SE, Talmud P. A common variant in the gene for lipoprotein lipase (Asp9→Asn): functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol. 1995;15:468-478.
15. Fisher RM, Mailly F, Peacock RE, Hamsten A, Seed M, Yudkin JS, Beisiegel U, Feussner G, Miller G, Humphries SE, Talmud PJ. Interaction of the lipoprotein lipase asparagine 291→serine mutation with body mass index determines elevated plasma triacylglycerol concentrations: a study in hyperlipidaemic subjects, myocardial infarction survivors and healthy adults. J Lipid Res. 1995;36:2104-2112.
16. Reymer PWA, Gagné E, Groenemeyer BE, Zhang H, Forsyth I, Jansen H, Seidell JC, Kromhout D, Kastelein J, Hayden MR. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nat Genet. 1995;10:28-34.
17. 9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. Circulation. 1996;94:1913-1918.
18. Kobayashi J, Nishida T, Ameis D, Stahnke G, Schotz MC, Hashimoto H, Fukamachi I, Shirai K, Saito Y, Yoshida S. A heterozygous mutation (the codon for Ser447 - a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem Biophys Res Commun. 1992;182:70-77.
19. Zhang H, Henderson H, Gagne SE, Clee SM, Miao L, Liu G, Hayden MR. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim Biophys Acta. 1996;1302:159-166.